$TransMedics Group, Inc.(TMDX)$ is a medical technology company specializing in organ transplant therapy. Founded in 1998 and headquartered in Andover, Massachusetts, TransMedics has developed a proprietary Organ Care System (OCS) designed to improve the transportation, preservation, and viability of donor organs. By revolutionizing how organs are preserved and transported, TransMedics is addressing some of the critical limitations in traditional transplant medicine.
Traditional organ preservation relies on cold static storage (ice-based methods), which significantly limits the viability window of donor organs, often resulting in wasted organs and increased mortality rates.
TransMedics’ solution — the Organ Care System (OCS) — is a portable, warm perfusion and monitoring system that keeps donor organs alive and functioning outside the body by mimicking the human body’s conditions. They currently offer OCS for:
• Heart (OCS Heart)
• Lung (OCS Lung)
• Liver (OCS Liver)
This method can extend preservation times, improve transplant outcomes, increase the usable donor pool, and allow surgeons to assess organ function in real-time before transplant, leading to better patient outcomes.
Comments